The AA Research and Education Project will issue bulletins on key points to help medical practitioners and those persons who have AA. We consider AA to be an urgent public health issue and ask all receivers of these bulletins to share them with concerned parties.

Doctors throughout the country are beginning to recognize and treat AA and other spinal canal inflammatory disorders.  In every case a patient has taken our materials to a local physician who becomes interested and knowledgeable.  We recommend that every person with AA start self-treatment and take educational materials to their local physicians.

Click Blue Link to Download Newest Bulletins of 2022

Bulletin 85 – Oral and Nasal Ketorolac to Treat AA

Bulletin 84 – Cytokine Panel: a new tool in AA treatment

Bulletin 83 – Administration of Four Consistent Agents for AA

Bulletin 82 – Autoimmune-Collagen Conditions Preceding AA

Bulletin 81 – How Epstein Barr virus causes AA

Bulletin 80 – How Collagen Disease Causes AA

Bulletin 79 – Collagen disease is a major cause of AA

Bulletin 78 – Neuropathic Pain

Bulletin 77 – Complications of spinal fluid leaks

Bulletin 76 – Why AA causes spinal fluid leaks

Bulletin 75 – Adhesive Arachnoiditis and the Intractable Pain Syndrome

Bulletin 74 – Rocking Chair Therapy

Bulletin 73 – Nutritional Measures for AA

Bulletin 72 – The “Empty Sac” Sign – What does it mean?

Bulletins Posted in 2021

Bulletin 71 – How to Improve Pain Control

Bulletin 70 – Time Frame and Process to Developing AA

Bulletin 69 – Acetazolamide for Headaches, Blurred Vision, and Dizziness

Bulletin 68 – Protocol First-Then Try New Treatments

Bulletin 67 – Just What is Lumbar-Sacral Adhesive Arachnoiditis?

Bulletin 66 – Steps to Take if Your Condition is Deteriorating

Bulletin 65 – Ancient History Underpins Three Component Protocol

Bulletin 64 – Are You Ready for Your Next Flare?

Bulletin 63 – Symptom Criteria for Diagnosis of AA

Bulletin 62 – Diagnosis of Lumbar AA – No.-2

Bulletin 61 – Diagnosis of AA – No.1 in a Series

Bulletin 60 – Nutrition Measures to Repair Damaged Nerves

Bulletin 59 – Lumbar-Sacral AA Update 2021 Part 2

Bulletin 58 – Lumbar-Sacral AA Update 2021-Part-1

Bulletin 57 – Blood Test for AA-Revised 3/22

Bulletin 56 – Emergency Treatment After Spinal Tap or Epidural Injection

Bulletin 55 – Human Chorionic Gonadotropin for AA

Bulletin 54 – How to Increase Your Oxygen Intake

Bulletin 53 – Alternatives to Oral, Prescription Corticosteroids

Bulletin 52 – Palmitoylethanolamide (PEA)

Bulletin 51 – MRI Series: Protruding Discs

Bulletin 50 – Inflammatory or Damaged Nerve Pain

Bulletin 49 – Topical Medication

Bulletin 48 – Three Key Elements of AA Treatment

Bulletin 47 – Spinal Fluid Flow Exercises

Bulletin 46 – Dosage of Monthly Injection for AA

Bulletin 45 – Which painful condition do you have?

Bulletin 44 – Try A Monthly Shot for AA

Bulletin 43 – Screening Test for Multi-System Collagen Disease

Bulletin 42 – Best Vitamins and Minerals

Bulletin 41 – Autoimmune and Allergic Reactions

Bulletin 40 – Water Soaking Treatment for AA

Bulletins – 2020

Bulletin 1 – AA is No Longer a Rare Disease

Bulletin 2 – Causes of AA in the 21st Century

Bulletin 3 – Drugs That Reduce Inflammation

Bulletin 4 – Physical Measures for Care of AA

Bulletin 5 – Getting Started to Deal with AA

Bulletin 6 – Anabolic Measures for Persons with AA and EDS

Bulletin 7 – Myths About Adhesive Arachnoiditis

Bulletin 8 – AA is Similar to RA

Bulletin 9 – Consequences and Complications-Revised 3/22

Bulletin 10 – Naltrexone Maximizing Its Effectiveness

Bulletin 11 – Ketorolac Essential for Most Persons with AA

Bulletin 12 – Fear of Corticosteroids is a Barrier

Bulletin 13 – Clinical Profile of 80 AA Cases

Bulletin 14 – AA is a Tumor or Mass in the Spinal Canal

Bulletin 15 – 3 Component Treatment to Tackle AA – 2021

Bulletin 16 – Intractable Pain Syndrome

Bulletin 17 – Eye, Ear, Nasal Symptoms with AA

Bulletin 18 – AA is the End Stage of Intraspinal Canal Inflammation

Bulletin 19 – Spinal Fluid Seepage

Bulletin 20 – Intraspinal Canal Inflammatory Disorders

Bulletin 21 – Best Drugs Series – Feature: Pregnenolone

Bulletin 22 – Evaluation After Presumptive MRI Diagnosis

Bulletin 23 – Stages and Categorization of AA

Bulletin 24 – Best Doctors to Treat Inflammatory Disorders

Bulletin 25 – Cervical Arachnoiditis

Bulletin 26 – Best Drugs Series – Feature: Ketorolac

Bulletin 27 – Starting Medical Treatment Protocol

Bulletin 28 – Do You Have Neuroinflammation?

Bulletin 29 – Copper-Magnets-Acupuncture: Do They Work?

Bulletin 30 – Corticosteroids Essential for AA

Bulletin 31 – Great Progress with AA

Bulletin 32 – Therapeutic Trial to Detect Intraspinal Canal Inflammation

Bulletin 33 – Association of EDS and Spinal Inflammatory Disorders

Bulletin 34 – Rationale for 3-Component Treatment

Bulletin 35 – Protruding Discs a Cause of AA

Bulletin 36 – Difference Between ARC and AA

Bulletin 37 – Tissue Building Hormones

Bulletin 38 – Non-Prescription Anti-Inflammatory Agents

Bulletin 39 – Build-Your-Program